cGAS inhibitors (IFM Due/Novartis)

N/A

Report date: 2025/03/18 18:08:48
NME

Base Information

Drug NamecGAS inhibitors (IFM Due/Novartis)
Drug Alias NamecGAS inhibitors (IFM Due)cyclic GMP-AMP synthase inhibitors (IFM Due/Novartis)cyclic GMP-AMP synthase inhibitors (IFM Due)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIFM Due Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesIFM Due Inc
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A